These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 17873320

  • 1. Intercellular adhesion molecule 1 gene polymorphisms do not contribute to Graves' disease in Chinese patients.
    Wang S, Sun H, Chen HY, Zhao ZF, Yang Y, Zhao YJ, Cui B, Ning G.
    Endocrine; 2007 Apr; 31(2):114-8. PubMed ID: 17873320
    [Abstract] [Full Text] [Related]

  • 2. Intercellular adhesion molecule 1 gene polymorphisms in Graves' disease.
    Kretowski A, Wawrusiewicz N, Mironczuk K, Mysliwiec J, Kretowska M, Kinalska I.
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4945-9. PubMed ID: 14557478
    [Abstract] [Full Text] [Related]

  • 3. ICAM1 K469E and E-selectin S128R polymorphisms could predispose to increased autoantibody production and TSH suppression in Graves' disease.
    Kanmaz-Özer M, Doğru-Abbasoğlu S, Vural P, Özderya A, Karadağ B, Uysal M.
    Mol Biol Rep; 2013 Mar; 40(3):2717-22. PubMed ID: 23242661
    [Abstract] [Full Text] [Related]

  • 4. TNFSF15 Polymorphisms are Associated with Graves' Disease and Graves' Ophthalmopathy in a Han Chinese Population.
    Zhang M, Liu S, Xu J, Lv S, Fan Y, Zhang Y, Zhang Y, Wu Y, Su Y, Yu H, Song S, He J, Li H.
    Curr Eye Res; 2020 Jul; 45(7):888-895. PubMed ID: 31869260
    [Abstract] [Full Text] [Related]

  • 5. The A946T polymorphism in the interferon induced helicase gene does not confer susceptibility to Graves' disease in Chinese population.
    Zhao ZF, Cui B, Chen HY, Wang S, Li I, Gu XJ, Qi L, Li XY, Ning G, Zhao YJ.
    Endocrine; 2007 Oct; 32(2):143-7. PubMed ID: 18026693
    [Abstract] [Full Text] [Related]

  • 6. The Role of FOXP3 Polymorphisms in Graves' Disease with or without Ophthalmopathy in a Turkish Population.
    Yaylacıoğlu Tuncay F, Serbest Ceylanoğlu K, Güntekin Ergün S, Ergün G, Konuk O.
    Turk J Ophthalmol; 2024 Apr 19; 54(2):69-75. PubMed ID: 38645270
    [Abstract] [Full Text] [Related]

  • 7. Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves' disease in a Japanese population.
    Ichimura M, Kaku H, Fukutani T, Koga H, Mukai T, Miyake I, Yamada K, Koda Y, Hiromatsu Y.
    Thyroid; 2008 Jun 19; 18(6):625-30. PubMed ID: 18578611
    [Abstract] [Full Text] [Related]

  • 8. Polymorphisms of endothelin 1 (G5665T and T-1370G) and endothelin receptor type A (C+70G and G-231A) in Graves' disease.
    Aydın AF, Develi-İş S, Doğru-Abbasoğlu S, Vural P, Ozderya A, Karadağ B, Uysal M.
    Int Immunopharmacol; 2014 Jan 19; 18(1):198-202. PubMed ID: 24291390
    [Abstract] [Full Text] [Related]

  • 9. Association study of endometriosis and intercellular adhesion molecule-1 (ICAM-1) gene polymorphisms in a Japanese population.
    Yamashita M, Yoshida S, Kennedy S, Ohara N, Motoyama S, Maruo T.
    J Soc Gynecol Investig; 2005 May 19; 12(4):267-71. PubMed ID: 15866119
    [Abstract] [Full Text] [Related]

  • 10. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
    Yin X, Latif R, Bahn R, Tomer Y, Davies TF.
    Thyroid; 2008 Nov 19; 18(11):1201-6. PubMed ID: 18925838
    [Abstract] [Full Text] [Related]

  • 11. [Effects of ICAM-1 gene K469E, K56M polymorphisms on plasma sICAM-1 expression levels in Chinese Yugur, Tibetan and Han nationalities].
    Wang MY, Bai DC, Zhu P, Fu Y, Bu DF, Zhang Y.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct 19; 20(5):1205-11. PubMed ID: 23114149
    [Abstract] [Full Text] [Related]

  • 12. Lack of association of interleukin-18 gene polymorphisms with susceptibility of Japanese populations to Graves' disease or Graves' ophthalmopathy.
    Mukai T, Hiromatsu Y, Ichimura M, Fukutani T, Kaku H, Miyake I, Shoji S, Koda Y, Bednarczuk T.
    Thyroid; 2006 Mar 19; 16(3):243-8. PubMed ID: 16571086
    [Abstract] [Full Text] [Related]

  • 13. Predisposition to Graves' disease and Graves' ophthalmopathy by genetic variants of IL2RA.
    Du J, Wang X, Tan G, Wei W, Zhou F, Liang Z, Li H, Yu H.
    J Mol Med (Berl); 2021 Oct 19; 99(10):1487-1495. PubMed ID: 34287665
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-13 gene polymorphisms in patients with Graves' disease.
    Bednarczuk T, Placha G, Jazdzewski K, Kurylowicz A, Kloza M, Makowska U, Hiromatsu Y, Nauman J.
    Clin Endocrinol (Oxf); 2003 Oct 19; 59(4):519-25. PubMed ID: 14510917
    [Abstract] [Full Text] [Related]

  • 15. The common -318C/T polymorphism in the promoter region of CTLA4 gene is associated with reduced risk of ophthalmopathy in Chinese Graves' patients.
    Han SZ, Zhang SH, Li R, Zhang WY, Li Y.
    Int J Immunogenet; 2006 Aug 19; 33(4):281-7. PubMed ID: 16893393
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Association of CTLA-4 and IL-13 gene polymorphisms with Graves' disease and ophthalmopathy in Chinese children.
    Chong KK, Chiang SW, Wong GW, Tam PO, Ng TK, Hu YJ, Yam GH, Lam DS, Pang CP.
    Invest Ophthalmol Vis Sci; 2008 Jun 19; 49(6):2409-15. PubMed ID: 18296657
    [Abstract] [Full Text] [Related]

  • 18. Intercellular adhesion molecule-1 and interleukin-6 gene polymorphisms in patients with advanced-stage endometriosis.
    Chae SJ, Lee GH, Choi YM, Hong MA, Kim JM, Lee KS, Ku SY, Moon SY.
    Gynecol Obstet Invest; 2010 Jun 19; 70(1):34-9. PubMed ID: 20160446
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.